Viewpoint: Why assisted reproduction needs to be more comprehensively regulated

Credit: Zac Freeland/Vox
Credit: Zac Freeland/Vox

The United States fertility market is growing very rapidly, and is projected to reach $15.4 billion in 2023, more than double what it was in 2017… Yet the sector remains curiously under-regulated, despite many calls to confront the numerous known issues, including health risks, financial exploitation, and repeated scandals in which doctors have surreptitiously used their own sperm.

[According to a 2018 report by the CDC and SART,] the industry reported 54,069 “transfers” (attempts to initiate pregnancies with embryos created in vitro) for women under 35; only 48.8% resulted in a live birth. The percentages fall in each higher age group; at 41-42, chances of a live birth are down to 26.6% and at 43 or older, 12.0%.

In short, most attempts at using ART fail.


Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

[Concerningly, out of 456 clinics analyzed] 43 clinics did not report [data], of which 26 are still in operation, but none of them appear to be subject to any penalty. That’s how little oversight the assisted reproduction industry gets away with.

For assisted reproduction, the US is regularly described as the “Wild West.” It’s past time for regulators to step in, and turn advice into legislation.

Read the original post

Related article:  Quickly-advancing human embryo research raises prickly ethical questions
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend